A new strain of bacteria treats liver and bowel diseases

The researchers said that bacteria genetically engineered to treat liver and bowel diseases are used to flush out toxins in the intestine.

The researchers tested a pioneering technique by creating a common bacterial strain, which removes excess ammonia in the body, where high concentrations of chemicals can be fatal, especially in liver patients and diseases rare genes.

According to the Daily Mail newspaper, the bacterium, produced by the American company "Scientology" in cooperation with the Massachusetts Institute of Technology, was able to reduce dangerous levels of ammonia, thus increasing the survival rate of mice.

"The mice treated with oral doses experienced a clear reduction in the amount of ammonia in the blood and an increased survival rate," the company said.

A small test on healthy people revealed that the bacteria were functioning as expected and were safe.

"These data show that we can create bacteria that can perform a specific function and inject them into humans," said Paul Miller, senior Scientologic scientist.

The drug, taken orally, uses "tools and principles of biological biology to formulate a strain of non-pathogenic bacteria to fill or provide specific functions that are lacking or are damaged by the disease."

The SYNB1020 is designed to respond to the lack of oxygen in the large intestine and convert ammonia to arginine, an amino acid. For safety reasons, microbes are genetically modified so that they can not reproduce, and the company now hopes to start developing the treatment.